<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82181">
  <stage>Registered</stage>
  <submitdate>31/07/2007</submitdate>
  <approvaldate>2/08/2007</approvaldate>
  <actrnumber>ACTRN12607000398404</actrnumber>
  <trial_identification>
    <studytitle>Falls prevention for stroke patients following discharge home: A randomised trial intervention</studytitle>
    <scientifictitle>Falls prevention for stroke patients following discharge home: A randomised trial evaluating a multifactorial falls prevention program</scientifictitle>
    <utrn />
    <trialacronym>FLASSH</trialacronym>
    <secondaryid>nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Stroke, falls</healthcondition>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Ischaemic</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Haemorrhagic</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Multifactorial individualised falls prevention program based on falls risk factors including a home exercise program, falls education, referral to address factors identified in falls risk assessment.  Home exercise program will continue for 12 months, education session will be undertaken within two weeks of randomisation to the intervention group (one session only).  The intervention will be additional to usual care, that is the therapy prescribed by the discharging facility.
</interventions>
    <comparator>Usual care which includes treatment as determined by the discharging facility.  This may include outpatient therapy, exercise.  Duration of usual care will vary according to the primary treating therapist, but generally will occur for approximately 3 months.</comparator>
    <control>Active</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome> Falls - time to first fall, fall rate.  Falls data will be collected prospectively via fall calendars which are filled out by the participants and returned to the researchers after the end of each month.  Data will be analysed at the end of 12 months.
</outcome>
      <timepoint>At one year after randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Falls efficacy</outcome>
      <timepoint>Measured at baseline, 4, 8 &amp; 12 months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Gait velocity</outcome>
      <timepoint>Measured at baseline and 12 months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Balance - step test</outcome>
      <timepoint>Measured at baseline and 12 months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Functional status</outcome>
      <timepoint>Measured at baseline and 12 months after randomisation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Stroke patients discharged home from sub-acute, at risk of falls due to previous fall or balance impairment.</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients discharged to residential care facilities, patients and carers without basic English.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subjects are enrolled if they meet inclusion criteria and provide consent.  Following baseline assessment, subjects are randomised to receive control or intervention.  Allocation occurs using sealed envelopes which contain group</concealment>
    <sequence>computerised sequence generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures>The outcome assessor is blind</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/06/2006</anticipatedstartdate>
    <actualstartdate>1/09/2006</actualstartdate>
    <anticipatedenddate />
    <actualenddate>11/11/2008</actualenddate>
    <samplesize>214</samplesize>
    <actualsamplesize>156</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Professor Keith Hill</primarysponsorname>
    <primarysponsoraddress>34-54 Poplar Rd
Parkville VIC 3052</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health and Medical Research Council</fundingname>
      <fundingaddress>GPO Box 1421
Canberra aCT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Catherine Said</sponsorname>
      <sponsoraddress>Austin Health</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Shylie Mackintosh</sponsorname>
      <sponsoraddress>University of South Australia</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Craig Whitehead</sponsorname>
      <sponsoraddress>Repatriation General Hospital, Adelaide</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study aims to evaluate two approaches to reducing falls in people who have had a stroke, have a high risk of falls and are returning home.</summary>
    <trialwebsite />
    <publication>Batchelor, F. A., Hill, K. D., Mackintosh, S. F., Said, C. M., &amp; Whitehead, C. (2009). The FLASSH study: protocol for a randomised controlled trial evaluating falls prevention after stroke and two sub-studies. BMC Neurology, 9, 14. 

Batchelor, F. A., Hill, K. D., Mackintosh, S. F., Said, C. M., &amp; Whitehead, C. H. (2012). Effects of a multi-factorial falls prevention program in people with stroke returning home after rehabilitation: a randomized controlled trial. Archives of Physical Medicine &amp; Rehabilitation., 93, 1648-1655. 

Fryer, C. E., Mackintosh, S. F., Batchelor, F. A., Hill, K. D., &amp; Said, C. M. (2012). The effect of limited English proficiency on falls risk and falls prevention after stroke. Age and Ageing, 41, 104-107. 

</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Melbourne Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Western Health</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Repatriation General Hospital, Adelaide</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>St Margaret's Hospital, Adelaide</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Austin Health</ethicname>
      <ethicaddress />
      <ethicapprovaldate>26/04/2006</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Frances Batchelor</name>
      <address>National Ageing Research Institute
34-54 Poplar Rd
Parkville VIC 3052</address>
      <phone>+61383872383</phone>
      <fax>03 8387 2153</fax>
      <email>f.batchelor@nari.unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Frances Batchelor</name>
      <address>National Ageing Research Institute
34-54 Poplar Rd
Parkville VIC 3052</address>
      <phone>03 8387 2383</phone>
      <fax>03 8387 2153</fax>
      <email>f.batchelor@nari.unimelb.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Frances Batchelor</name>
      <address>National Ageing Research Institute
PO Box 2127 The Royal Melbourne Hospital
Parkville VIC 3052
Australia</address>
      <phone>+61383872383</phone>
      <fax />
      <email>f.batchelor@nari.unimelb.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>